Derivative of caffeic acid, oraposide, and cosmetic or pharmaceutical compositions, in particular dermatological compositions, containing it
US5719129A · kind A · utility
14Cited by
0References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 1993 |
| Grant date | Feb 17, 1998 |
| Priority date | — |
| Expiry date | Oct 15, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/004
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a new derivative of caffeic acid. This new derivative has the formula I below: ##STR1## in which one or more R independently represent a hydrogen atom, a C.sub.1 -C.sub.5 alkyl group, in particular methyl, and an acyl group, in particular a C.sub.1 -C.sub.6 group, in particular acetyl. This new derivative called oraposide is particularly useful for the preparation of cosmetic or pharmaceutical compositions, in particular dermatological compositions, as a result in particular of its activity against free radicals, inflammation and aging due to radiation exposure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.